Topics

Cutaneous sarcoidosis presenting as a cutaneous horn.

08:00 EDT 1st August 2019 | BioPortfolio

Summary of "Cutaneous sarcoidosis presenting as a cutaneous horn."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: Cutis
ISSN: 2326-6929
Pages: E28-E29

Links

DeepDyve research library

PubMed Articles [2754 Associated PubMed Articles listed on BioPortfolio]

Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.

Sarcoidosis and granuloma annulare (GA) are cutaneous granulomatous disorders that can be difficult to treat. There is evidence of underlying JAK-STAT pathway activation in sarcoidosis, suggesting JAK...

Natalizumab induced cutaneous sarcoidosis-like reaction.

We present a case of a drug-induced sarcoidosis -like reaction (DISR) occurring following initiation of Natalizumab for multiple sclerosis. The reaction was purely cutaneous, and disappeared following...

Cutaneous metastasis of endometrial carcinoma: an unusual and dramatic presentation.

Endometrial carcinoma is a common gynecologic malignancy in the United States, but it rarely progresses to disseminated disease. Cutaneous metastases are rare because of routine gynecologic examinatio...

Cutaneous collagenous vasculopathy: papular form.

Cutaneous collagenous vasculopathy is a rare clinicopathological entity, first described in 2000. Cutaneous collagenous vasculopathy has been considered a form of microangiopathy of superficial dermal...

First case of cutaneous sarcoidosis within tattoos under durvalumab.

Clinical Trials [1909 Associated Clinical Trials listed on BioPortfolio]

Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare

To investigate the ability of tofacitinib, a Janus kinase (JAK) inhibitor, to treat patients with cutaneous sarcoidosis and granuloma annulare during 6 months of therapy.

Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis

The purpose of this study is to determine the safety and efficacy of Humira in the treatment of cutaneous sarcoidosis.

Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis

The purpose of the study is to see if Humira is effective and safe in the treatment of sarcoidosis.

Trial of Antimycobacterial Therapy in Sarcoidosis

Growing research from independent laboratories provide an association between mycobacteria and sarcoidosis. More recent immunologic and molecular studies demonstrate immune responses to m...

Identification of the Cutaneous Microbiota in Patients With Cutaneous Infection (MICROBIOTA)

Identify the cutaneous microbiota on a cutaneous lesion (cellulite, wound, rash, etc.) on a swab, biopsies or abscess puncture and on "healthy" skin on a skin swab performed for cutaneous ...

Medical and Biotech [MESH] Definitions

A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals including rodents. The Leishmania mexicana complex causes both cutaneous (LEISHMANIASIS, CUTANEOUS) and diffuse cutaneous leishmaniasis (LEISHMANIASIS, DIFFUSE CUTANEOUS) and includes the subspecies amazonensis, garnhami, mexicana, pifanoi, and venezuelensis. L. m. mexicana causes chiclero ulcer, a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) in the New World. The sandfly, Lutzomyia, appears to be the vector.

A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.

A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).

A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals. It causes cutaneous (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), and mucocutaneous leishmaniasis (LEISHMANIASIS, MUCOCUTANEOUS) depending on the subspecies of this organism. The sandfly, Lutzomyia, is the vector. The Leishmania braziliensis complex includes the subspecies braziliensis and peruviana. Uta, a form of cutaneous leishmaniasis in the New World, is caused by the subspecies peruviana.

Skin lesions due to abnormal infiltration of MAST CELLS. Cutaneous mastocytosis is confined to the skin without the involvement of other tissues or organs, and is mostly found in children. The three major variants are: URTICARIA PIGMENTOSA; diffuse cutaneous mastocytosis; and SOLITARY MASTOCYTOMA OF SKIN.

Quick Search
DeepDyve research library

Searches Linking to this Article